Molnupiravir for Covid-19 in Nonhospitalized Patients. Reply

N Engl J Med. 2022 Mar 31;386(13):e32. doi: 10.1056/NEJMc2201612. Epub 2022 Mar 16.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • Cytidine / analogs & derivatives
  • Humans
  • Hydroxylamines

Substances

  • Hydroxylamines
  • Cytidine
  • molnupiravir